Not only were federal guidelines on reporting financial ties between doctors and drug or device makers 10 weeks late, the compliance deadline was delayed from Jan. 1 to an unspecified date. HHS will accept comments on the proposed guidelines until Feb. 17. "[W]hile the details of the national Sunshine rule emerge, our most important job is ensuring that our clients, health care providers and patients get past the headlines, understand the underlying issues and move forward," said Coalition for Healthcare Communication Executive Director John Kamp.

Related Summaries